Publications

Search for Publications

List of Publications

Sort by: Date | Author | Title

Vitfell-Rasmussen, J., Aggerholm-Pedersen, N., Knudsen, C. B., Madsen, K., Fiksen, L., Junker, N., Petersen, M. M., Kümler, T., Krarup-Hansen, A. & Engelmann, B. E. (2026). Cardiotoxicity, survival, and dexrazoxane use in patients with soft tissue sarcoma: a Danish population-based cohort study. Acta Oncologica, 65, 590-598. https://doi.org/10.2340/1651-226X.2026.45897
Handeland, A. H., Indelicato, D. J., Engeseth, G. M., Fjæra, L. F., Grewal, H. S., Ytre-Hauge, K. S., Muren, L. P., Lassen-Ramshad, Y., Henjum, H. & Stokkevåg, C. H. (2026). Voxel-Wise Case-Control Analysis of Dose, Linear Energy Transfer, and Symptomatic Brainstem Necrosis in Pediatric Brain Tumors Treated With Proton Therapy. International Journal of Radiation Oncology Biology Physics, 126(4), 1024-1033. https://doi.org/10.1016/j.ijrobp.2026.05.054
Cygler, J. E., Tanderup, K., Rosales, H. M. L., Fonseca, G. P., Johansen, J. & Beddar, S. (2026). In Vivo Dosimetry in Brachytherapy. In Comprehensive Brachytherapy: Physical and Clinical Aspects, Second Edition (pp. 359-386). CRC Press Inc.. https://doi.org/10.1201/9781003302742-30
Vitolo, U., Falchi, L., Andersson, P. O., Nijland, M., Offner, F., Snauwaert, S., Christensen, J. H., Clausen, M. R., Fosså, A., Prieto, P. G., Hawkes, E. A., Jørgensen, J. M., Karimi, Y. H., Lewerin, C., Vermaat, J. S. P., Wahlin, B. E., Patah, P., Morehouse, C., Risum, M. ... Brody, J. D. (2026). First-line treatment with epcoritamab in combination with bendamustine plus rituximab induces sustained remissions beyond 3 years in patients with follicular lymphoma. HemaSphere, 10(8), Article e70443. https://doi.org/10.1002/hem3.70443
Indira Chandran, V., Christiansen, S. H., Hansen, S. M., Larsen, A. N., Præstholm, S. M., Toft, N., Palarasah, Y., Skytthe, M. K., Moestrup, S. K., Grøntved, L., Wu, C., Sørensen, T. L. M., Mutsaers, H. A. M. & Graversen, J. H. (2026). Development and preclinical evaluation of an asialoglycoprotein receptor 1-targeted antibody-drug conjugate in hepatic inflammation. International Journal of Biological Macromolecules, 377, Article 153145. https://doi.org/10.1016/j.ijbiomac.2026.153145
Thomsen, K. L., Sharma, V., Jones, H., Daugaard Mikkelsen, A. C., Davies, N., Habtesion, A., Paaske, S. E., Macnaughtan, J., Martins, M. C., Gallego-Durán, R., Romero-Gómez, M., Hamilton-Dutoit, S., Rombouts, K., Jalan, R. & Mookerjee, R. P. (2026). Alpha 2A adrenergic receptor antagonism reduces fibrosis, inflammation and portal hypertension in models of chronic liver disease. JHEP Reports, 8(9), Article 101922. https://doi.org/10.1016/j.jhepr.2026.101922